Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study

被引:41
|
作者
Chen, Mu-Hong [1 ,2 ]
Li, Cheng-Ta [1 ,2 ,4 ]
Lin, Wei-Chen [2 ,4 ]
Hong, Chen-Jee [1 ,2 ,4 ]
Tu, Pei-Chi [1 ,2 ,3 ]
Bai, Ya-Mei [1 ,2 ]
Cheng, Chih-Ming [2 ]
Su, Tung-Ping [1 ,2 ,3 ,4 ,5 ]
机构
[1] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Psychiat, 201,Sec 2,Shih-Pai Rd, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Brain Sci, Taipei, Taiwan
[5] Gen Cheng Hsin Hosp, Dept Psychiat, Taipei, Taiwan
关键词
Ketamine; Treatment-resistant depression; PET; Supplementary motor area; Dorsal anterior cingulate cortex; UNIPOLAR DEPRESSION; RESIDUAL SYMPTOMS; PREFRONTAL CORTEX; PET SCANS; DISORDER; REMISSION; BRAIN; ADOLESCENTS; OUTCOMES; CARE;
D O I
10.1016/j.jad.2017.09.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A single low-dose ketamine infusion exhibited a rapid antidepressant effect within 1 h. Despite its short biological half-life (approximately 3 h), the antidepressant effect of ketamine has been demonstrated to persist for several days. However, changes in brain function responsible for the persistent antidepressant effect of a single low-dose ketamine infusion remain unclear Methods: Twenty-four patients with treatment-resistant depression (TRD) were randomized into three groups according to the treatment received: 0.5 mg/kg ketamine, 0.2 mg/kg ketamine, and normal saline infusion. Standardized uptake values (SUVs) of glucose metabolism measured through F-18-FDG positron-emission-tomography before infusion and 1 day after a 40-min ketamine or normal saline infusion were used for subsequent whole-brain voxel-wise analysis and were correlated with depressive symptoms, as defined using the Hamilton Depression Rating Scale-17 (HDRS-17) score Results: The voxel-wise analysis revealed that patients with TRD receiving the 0.5 mg/kg ketamine infusion had significantly higher SUVs (corrected for family-wise errors, P = 0.014) in the supplementary motor area (SMA) and dorsal anterior cingulate cortex (dACC) than did those receiving the 0.2 mg/kg ketamine infusion. The increase in the SUV in the dACC was negatively correlated with depressive symptoms at 1 day after ketamine infusion Discussion: The persistent antidepressant effect of a 0.5 mg/kg ketamine infusion may be mediated by increased activation in the SMA and dACC. The higher increase in dACC activation was related to the reduction in depressive symptoms after ketamine infusion. A 0.5 mg/kg ketamine infusion facilitated the glutamatergic neurotransmission in the SMA and dACC, which may be responsible for the persistent antidepressant effect of ketamine much beyond its half-life.
引用
收藏
页码:709 / 714
页数:6
相关论文
共 50 条
  • [31] Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study (vol 113, pg 507, 2021)
    Chen, Mu-Hong
    Kao, Chung-Feng
    Tsai, Shih-Jen
    Li, Cheng-Ta
    Lin, Wei-Chen
    Hong, Chen-Jee
    Bai, Ya-Mei
    Tu, Pei-Chi
    Su, Tung-Ping
    GENOMICS, 2022, 114 (01) : 470 - 470
  • [32] A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
    Singh, Jaskaran B.
    Fedgchin, Maggie
    Daly, Ella J.
    De Boer, Peter
    Cooper, Kimberly
    Lim, Pilar
    Pinter, Christine
    Murrough, James W.
    Sanacora, Gerard
    Shelton, Richard C.
    Kurian, Benji
    Winokur, Andrew
    Fava, Maurizio
    Manji, Husseini
    Drevets, Wayne C.
    Van Nueten, Luc
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (08): : 816 - 826
  • [33] Randomized, Double-Blind Study of Fixed-Dose Intranasal Esketamine Plus Oral Antidepressant vs. Active Control in Treatment-Resistant Depression
    Fedgchin, Maggie
    Trivedi, Madhukar
    Daly, Ella J.
    Melkote, Rama
    Lane, Rosanne
    Lim, Pilar
    Vitagliano, Dawn
    Blier, Pierre
    Fava, Maurizio
    Liebowitz, Michael
    Ravindran, Arun
    Gaillard, Raphael
    van den Ameele, Hans
    Manjii, Husseini
    Hough, David
    Drevets, Wayne C.
    Singh, Jaskaran B.
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 254 : 131 - 132
  • [34] Comparative study of low-dose ketamine infusion and repetitive transcranial magnetic stimulation in treatment-resistant depression: A posthoc pooled analysis of two randomized, double-blind, placebo-controlled studies
    Chen, Mu-Hong
    Cheng, Chih-Ming
    Li, Cheng-Ta
    Tsai, Shih-Jen
    Lin, Wei-Chen
    Bai, Ya-Mei
    Su, Tung-Ping
    PSYCHIATRY RESEARCH, 2022, 316
  • [35] Effects of melancholic features on positive and negative suicidal ideation in patients with treatment-resistant depression and strong suicidal ideation receiving low-dose ketamine infusion
    Chen, Mu-Hong
    Su, Tung-Ping
    Li, Cheng-Ta
    Lin, Wei-Chen
    Wu, Hui-Ju
    Tsai, Shih-Jen
    Bai, Ya-Mei
    Mao, Wei-Chung
    Tu, Pei-Chi
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2024, 274 (04) : 759 - 766
  • [36] A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Dose Frequency Study of Intravenous Ketamine in Patients with Treatment-Resistant Depression
    Singh, Jaskaran
    Fedgchin, Maggie
    Daly, Ella
    De Boer, Peter
    Cooper, Kimberly
    Lim, Pilar
    Pinter, Christine
    Murrough, James
    Sanacora, Gerard
    Shelton, Richard
    Kurian, Benji
    Winokur, Andrew
    Fava, Maurizio
    Manji, Husseini
    Drevets, Wayne
    Van Nueten, Luc
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 44S - 44S
  • [37] Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: A double-blind, placebo-controlled, randomized, longitudinal resting fMRI study
    Chen, Mu-Hong
    Lin, Wei-Chen
    Tu, Pei-Chi
    Li, Cheng-Ta
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Su, Tung-Ping
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 259 : 15 - 20
  • [38] Effects of low-dose ketamine infusion on vascular endothelial growth factor and matrix metalloproteinase-9 among patients with treatment-resistant depression and suicidal ideation
    Chen, Mu-Hong
    Lin, Wei-Chen
    Li, Cheng-Ta
    Wu, Hui-Ju
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Su, Tung-Ping
    Tu, Pei-Chi
    JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 165 : 91 - 95
  • [39] Antisuicidal Effect, BDNF Val66Met Polymorphism, and Low-Dose Ketamine Infusion: Reanalysis of Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression (AKSTP-TRD) (vol 251, pg 162, 2019)
    Chen, Mu-Hong
    Lin, Wei-Chen
    Wu, Hui-Ju
    Cheng, Chih-Ming
    Li, Cheng-Ta
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Su, Tung-Ping
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 274 : 1217 - 1217
  • [40] Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion
    Lin, Wei-Chen
    Su, Tung-Ping
    Li, Cheng-Ta
    Wu, Hui-Ju
    Tsai, Shih-Jen
    Bai, Ya-Mei
    Tu, Pei-Chi
    Chen, Mu-Hong
    JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (08) : 795 - 801